Cargando…

Small interfering RNA-based molecular therapy of cancers

RNA interference (RNAi) has become a gold standard for validating gene function in basic life science research and provides a promising therapeutic modality for cancer and other diseases. This mini-review focuses on the potential of small interfering RNAs (siRNAs) in anticancer treatment, including...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Wei, Chen, Wangbing, Yu, Wendan, Huang, Wenlin, Deng, Wuguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sun Yat-sen University Cancer Center 2013
Materias:	Mini Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845562/ https://www.ncbi.nlm.nih.gov/pubmed/23327796 http://dx.doi.org/10.5732/cjc.012.10280

Ejemplares similares

RFPL3 and CBP synergistically upregulate hTERT activity and promote lung cancer growth
por: Qin, Yu, et al.
Publicado: (2015)

TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling
por: Fu, Lingyi, et al.
Publicado: (2014)

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy
por: Miele, Evelina, et al.
Publicado: (2012)

Small Interfering RNA in Colorectal Cancer Liver Metastasis Therapy
por: Xie, Junlin, et al.
Publicado: (2022)

Ursolic Acid Simultaneously Targets Multiple Signaling Pathways to Suppress Proliferation and Induce Apoptosis in Colon Cancer Cells
por: Wang, Jingshu, et al.
Publicado: (2013)

XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers
por: Zhang, Zhifeng, et al.
Publicado: (2017)

High expression of Y-box-binding protein 1 correlates with poor prognosis and early recurrence in patients with small invasive lung adenocarcinoma
por: Zhao, Shilei, et al.
Publicado: (2016)

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth
por: Fu, Lingyi, et al.
Publicado: (2013)

Upregulation of Cleavage and Polyadenylation Specific Factor 4 in Lung Adenocarcinoma and Its Critical Role for Cancer Cell Survival and Proliferation
por: Chen, Wangbing, et al.
Publicado: (2013)

Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth
por: Zhang, Ningning, et al.
Publicado: (2017)

Role of long non‐coding RNA in drug resistance in non‐small cell lung cancer
por: Wang, Leirong, et al.
Publicado: (2018)

Delivery of therapeutic small interfering RNA: The current patent-based landscape
por: Chen, Yu, et al.
Publicado: (2022)

Immunoliposomes-mediated small interfering RNA therapy: A novel approach for the treatment of cancer
por: Khan, Arif
Publicado: (2019)

Delivering Small Interfering RNA for Novel Therapeutics
por: Lu, Patrick Y., et al.
Publicado: (2008)

Updates in Small Interfering RNA for the Treatment of Dyslipidemias
por: Carugo, S., et al.
Publicado: (2023)

Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)

Combined Small Interfering RNA Therapy and In Vivo Magnetic Resonance Imaging in Islet Transplantation
por: Wang, Ping, et al.
Publicado: (2011)

Small Interfering RNA for Gliomas Treatment: Overcoming Hurdles in Delivery
por: Teng, Xin-Qi, et al.
Publicado: (2022)

Chemically modified small interfering RNA targeting Hedgehog signaling pathway for rheumatoid arthritis therapy
por: Lin, Lang, et al.
Publicado: (2022)

AQP3 small interfering RNA and PLD2 small interfering RNA inhibit the proliferation and promote the apoptosis of squamous cell carcinoma
por: Wang, Xiaoyong, et al.
Publicado: (2017)

Molecular Basis for the Immunostimulatory Potency of Small Interfering RNAs
por: Sioud, Mouldy, et al.
Publicado: (2006)

Secondary Small Interfering RNA-Based Silencing Tools in Plants: An Update
por: Carbonell, Alberto
Publicado: (2019)

Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases
por: Kurakula, Harshini, et al.
Publicado: (2023)

Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology
por: Huang, Jinxing, et al.
Publicado: (2022)

Transcriptional coactivator CBP upregulates hTERT expression and tumor growth and predicts poor prognosis in human lung cancers
por: Guo, Wei, et al.
Publicado: (2014)

Small Interfering RNA Inhibition of Andes Virus Replication
por: Chiang, Cheng-Feng, et al.
Publicado: (2014)

Antisense Oligonucleotides and Small Interfering RNA for the Treatment of Dyslipidemias
por: Gareri, Clarice, et al.
Publicado: (2022)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2019)

Ret finger protein-like 3 promotes tumor cell growth by activating telomerase reverse transcriptase expression in human lung cancer cells
por: Chen, Wangbing, et al.
Publicado: (2014)

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer
por: Feng, Xu, et al.
Publicado: (2017)

Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer
por: Storey, Claire L., et al.
Publicado: (2020)

Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes
por: Liu, Jianye, et al.
Publicado: (2019)

The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancers
por: Minciuna, Corina-Elena, et al.
Publicado: (2022)

Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation
por: Lin, Jiatian, et al.
Publicado: (2020)

Functional Nanostructures for Effective Delivery of Small Interfering RNA Therapeutics
por: Hong, Cheol Am, et al.
Publicado: (2014)

Phenotypic Alteration of BMDM In Vitro Using Small Interfering RNA
por: Halimani, Noreen, et al.
Publicado: (2022)

Potential Application of Small Interfering RNA in Gastro-Intestinal Tumors
por: Losurdo, Pasquale, et al.
Publicado: (2022)

Small interfering RNAs on top
Publicado: (2004)

Small Interfering RNA Therapeutics in Hypertension: A Viewpoint on Vasopressor and Vasopressor‐Sparing Strategies for Counteracting Blood Pressure Lowering by Angiotensinogen–Targeting Small Interfering RNA
por: Ranasinghe, Priyanga, et al.
Publicado: (2022)

Molecular Bases for the Recognition of Tyrosine-based Sorting Signals
por: Bonifacino, Juan S., et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_ouaa3kdsdmrd2r48qvmjfpr5jh